| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 91936 |
Gd-DOTA-Peptide |
168 |
zyl |
2024-11-27 |
| 91937 |
2.3-O-异丙基烯丙基醚基-2,6-二-O-戊基-β-环糊精接枝聚硅氧烷 |
140 |
h |
2024-11-27 |
| 91938 |
3,6-双(氨基硝基胍基)-1,2,4,5-四嗪(BANTz) |
140 |
WYQ |
2024-11-27 |
| 91939 |
HSA-GGD-ICG ,人血清白蛋白-GGD-吲哚菁绿 |
191 |
kx |
2024-11-27 |
| 91940 |
β-环糊精-聚乙二醇单甲醚-聚乳酸 sPEL/CDs |
171 |
h |
2024-11-27 |
| 91941 |
3-(氨基硝基胍基)-6-(3,5-二甲基吡唑)-1,2,4,5-四嗪(ANPTz) |
145 |
WYQ |
2024-11-27 |
| 91942 |
3,6-双(1-氢-1,2,3,4-四唑-5-氨基)-1,2,4,5-四嗪(BTATz)离子盐 |
165 |
WYQ |
2024-11-27 |
| 91943 |
DOTA mono-NHS ester,170908-81-3 羟基琥珀酰亚胺-四氮杂环十二烷四乙酸 |
194 |
zyl |
2024-11-27 |
| 91944 |
NTR激活MRI造影剂Gd-DOTA-PNB |
248 |
kx |
2024-11-27 |
| 91945 |
环糊精/聚丙烯酸/聚乙二醇三元复合物 β-CD/PAA/PEG |
160 |
h |
2024-11-27 |
| 91946 |
6-(5-氨基-1H-四唑)-1,2,4,5-四嗪-3-酮钾盐(K2·TATzO) |
138 |
WYQ |
2024-11-27 |
| 91947 |
6-(5-氨基-1H-四唑)-1,2,4,5-四嗪-3-酮(TATzO) |
160 |
WYQ |
2024-11-27 |
| 91948 |
DOTA-Octreotide;放射性示踪剂;大环配体多肽 |
145 |
zcy |
2024-11-27 |
| 91949 |
Gd-DOTA-E-[c(RGDf K)]2 , Gd-DOTA修饰靶向双环肽E-[c(R GDf K)]2 |
149 |
kx |
2024-11-27 |
| 91950 |
环糊精基梳状多聚轮烷(CD-PR) |
135 |
h |
2024-11-27 |
| 91951 |
DOTA Ala Ala COOH DOTA-AA-OH DOTA-丙氨酸-丙氨酸-羧酸 |
145 |
zyl |
2024-11-27 |
| 91952 |
DOTA-E「c(RGDfK)2」,双环肽螯合物 |
129 |
zcy |
2024-11-27 |
| 91953 |
peptide-DOTA-Eu ,炔基化的peptide和叠氮化的Eu络合物 |
193 |
kx |
2024-11-27 |
| 91954 |
环糊精基梳状多聚轮烷(CD-PR) |
189 |
h |
2024-11-27 |
| 91955 |
DOTA-Glu(cyclo(Arg-Gly-Asp-DPhe-Lys))2;肽类配体 |
189 |
zcy |
2024-11-27 |
| 91956 |
亚甲基蓝/β-环糊精/聚乙酰苯胺复合物 β-CD/MB/AMD |
210 |
h |
2024-11-27 |
| 91957 |
DUPAaFFC-AMF-DOTA-Nd ,8-氨基辛酸-苯丙氨酸-苯丙氨酸-半胱氨酸-AMF-DOTA-Nd |
122 |
kx |
2024-11-27 |
| 91958 |
β-环糊精改性酰胺型聚羧酸减水剂 β-CD-MPC |
156 |
h |
2024-11-27 |
| 91959 |
DOTA-fCYwKTCT-CHO,204318-14-9 |
152 |
zcy |
2024-11-27 |
| 91960 |
聚多巴胺改性柠檬酸偶联β-环糊精-纳米银 CD-CA/PDA-xAg |
240 |
h |
2024-11-27 |
| 91961 |
DOTA-NKL , DOTA偶联肽D-K6L9修饰NGR |
138 |
kx |
2024-11-27 |
| 91962 |
4-硝氨基-N-(3-硝氨基-[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪)1,2,5-噁二唑-3-胺 |
166 |
WYQ |
2024-11-27 |
| 91963 |
聚苯胺-β-环糊精包合物 PANI-β-CD |
173 |
h |
2024-11-27 |
| 91964 |
3-氨基-6-(3,5-二甲基吡唑)-1,2,4-三唑并[4,3-b][1,2,4,5]四嗪 |
264 |
WYQ |
2024-11-27 |
| 91965 |
4-硝氨基-N-(3-硝氨基-[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪)1,2,5-噁二唑-3-氨二4-氨基-1,2,4-三唑盐 |
186 |
WYQ |
2024-11-27 |
| 91966 |
聚六亚甲基单胍接枝β-环糊精 PHMG-β-CD |
156 |
h |
2024-11-27 |
| 91967 |
4-硝氨基-N-(3-硝氨基-[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪)1,2,5-噁二唑-3-氨二1,2,4-三唑盐 |
176 |
WYQ |
2024-11-27 |
| 91968 |
4-硝氨基-N-(3-硝氨基-[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪)1,2,5-噁二唑-3-氨二羟胺盐 |
213 |
WYQ |
2024-11-27 |
| 91969 |
四嗪吡啶类配合物{[Cu(3-bptz)0.5(L-asp)]·1.5H2O}n(6) |
165 |
WYQ |
2024-11-27 |
| 91970 |
DOTA标记的c(RGDfK)环肽,DOTA-cyclo(RGDfK) |
165 |
zcy |
2024-11-27 |
| 91971 |
聚乙二醇-聚乳酸共聚物 MPEG-PLA4armPEG-PLA |
136 |
h |
2024-11-27 |
| 91972 |
四嗪吡啶类配合物{[Co(4-bptz)(btc)]·2H2O·DMF}n(5) |
206 |
WYQ |
2024-11-27 |
| 91973 |
四嗪吡啶类配合物{[Mn(4-bptz)(Hbtc)]·H2O·2DMF}n(4) |
135 |
WYQ |
2024-11-27 |
| 91974 |
DOTA-Ala-Ala-Tyr-COOH,DOTA-丙氨酸-丙氨酸-酪氨酸-羧酸 |
132 |
zcy |
2024-11-27 |
| 91975 |
4-硝氨基-N-(3-硝氨基-[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪)1,2,5-噁二唑-3-氨二肼盐 |
160 |
WYQ |
2024-11-27 |
| 91976 |
DOTA-TMTP1 ,TMTP1偶联双功能螯合剂1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA) |
173 |
kx |
2024-11-27 |
| 91977 |
4-硝氨基-N-(3-硝氨基-[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪)1,2,5-噁二唑-3-氨二铵盐 |
161 |
WYQ |
2024-11-27 |
| 91978 |
DOTA-TATE acetate,DOTA-3-酪氨酰基-奥曲肽醋酸盐 |
129 |
zcy |
2024-11-27 |
| 91979 |
4-硝氨基-N-(3-硝氨基-[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪)1,2,5-噁二唑-3-氨二钠盐 |
187 |
WYQ |
2024-11-27 |
| 91980 |
p-NCS-Bz-DOTA-GA ,CAS:2125661-64-3 |
144 |
zyl |
2024-11-27 |